{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:32:46Z","timestamp":1773336766919,"version":"3.50.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tmaid.2025.102918","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:34:45Z","timestamp":1760542485000},"page":"102918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical, therapeutic, and stigma-related challenges in leprosy and the emerging role of apremilast in managing leprosy reactions"],"prefix":"10.1016","volume":"68","author":[{"given":"Diego","family":"Gayoso Cantero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Fern\u00e1ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Chamorro-Tojeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Quereda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Tato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Berna-Rico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Naharro-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Perez-Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2025.102918_bib1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(04)15952-7","article-title":"Leprosy","volume":"363","author":"Britton","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2025.102918_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/8652062","article-title":"Leprosy: a review of epidemiology, clinical diagnosis, and management","volume":"2022","author":"Chen","year":"2022","journal-title":"J Trop Med"},{"key":"10.1016\/j.tmaid.2025.102918_bib3","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1126\/science\/1109759","article-title":"On the origin of leprosy","volume":"308","author":"Monot","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.tmaid.2025.102918_bib4","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/ng.477","article-title":"Comparative genomic and phylogeographic analysis of Mycobacterium leprae","volume":"41","author":"Monot","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.tmaid.2025.102918_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.clindermatol.2022.07.004","article-title":"History of leprosy in India: an overview of historic and modern contributions","volume":"40","author":"Sil","year":"2022","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.tmaid.2025.102918_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12915-021-01120-2","article-title":"Mycobacterium leprae diversity and population dynamics in medieval Europe from novel ancient genomes","volume":"19","author":"Pfrengle","year":"2021","journal-title":"BMC Biol"},{"key":"10.1016\/j.tmaid.2025.102918_bib7","article-title":"Chemotherapy of leprosy for control programmes","year":"1982","journal-title":"WHO Technical Report Series 675."},{"key":"10.1016\/j.tmaid.2025.102918_bib8","series-title":"Resolution A44\/VR\/11","year":"1991"},{"key":"10.1016\/j.tmaid.2025.102918_bib9","volume":"vol. 37","year":"2023"},{"key":"10.1016\/j.tmaid.2025.102918_bib10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tmaid.2016.06.008","article-title":"Imported and autochthonous leprosy presenting in Madrid (1989-2015): a case series and review of the literature","volume":"14","author":"Norman","year":"2016","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib11","series-title":"NHDP guide to the management of hansen's disease","year":"2017"},{"key":"10.1016\/j.tmaid.2025.102918_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/qjmed\/94.4.207","article-title":"The diagnosis of leprosy is delayed in the United Kingdom","volume":"94","author":"Lockwood","year":"2001","journal-title":"QJM"},{"key":"10.1016\/j.tmaid.2025.102918_bib13","first-page":"9","article-title":"Leprosy in New Zealand: an epidemiological update","volume":"128","author":"Yu","year":"2015","journal-title":"New Zeland Medical Journal"},{"key":"10.1016\/j.tmaid.2025.102918_bib14","first-page":"87","volume":"vol. 1","year":"2018"},{"key":"10.1016\/j.tmaid.2025.102918_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/499278","article-title":"Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy","volume":"193","author":"Moet","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib16","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4269\/ajtmh.2008.78.518","article-title":"Transmission of leprosy: a study of skin and nasal secretions of household contacts of leprosy patients using PCR","volume":"78","author":"Job","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2025.102918_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fvets.2019.00008","article-title":"British red squirrels remain the only known wild rodent host for leprosy Bacilli","volume":"6","author":"Schilling","year":"2019","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.tmaid.2025.102918_bib18","article-title":"HRSA NHDP guide to the management of hansen\u2019s disease: national hansen\u2019s disease programs","author":"Hansen","year":"2017","journal-title":"NHDP"},{"key":"10.1016\/j.tmaid.2025.102918_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oxfordjournals.epirev.a036245","article-title":"LEPROSY: the epidemiology of a slow bacterium","volume":"4","author":"Fine","year":"1982","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.tmaid.2025.102918_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/8652062","article-title":"Leprosy: a review of epidemiology, clinical diagnosis, and management","volume":"2022","author":"Chen","year":"2022","journal-title":"J Trop Med"},{"key":"10.1016\/j.tmaid.2025.102918_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijmr.IJMR_2625_19","article-title":"Leprosy stigma & the relevance of emergent therapeutic options","volume":"151","author":"Sardana","year":"2020","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.tmaid.2025.102918_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209676","article-title":"Perceived stigma of leprosy among community members and health care providers in lalitpur district of Nepal: a qualitative study","volume":"13","author":"Marahatta","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tmaid.2025.102918_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005716","article-title":"A leprosy clinical severity scale for erythema nodosum leprosum: an international, multicentre validation study of the ENLIST ENL severity scale","volume":"11","author":"Walker","year":"2017","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib24","series-title":"International textbook of leprosy","article-title":"Sunil. Clinical diagnosis of leprosy","author":"Kumar","year":"2017"},{"key":"10.1016\/j.tmaid.2025.102918_bib25","first-page":"255","article-title":"Classification of leprosy according to immunity. A five-group system","volume":"34","author":"Ridley","year":"1966","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1416177","article-title":"An update on leprosy immunopathogenesis: systematic review","volume":"15","author":"Silva","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmaid.2025.102918_bib27","volume":"vol. 968","year":"2012"},{"key":"10.1016\/j.tmaid.2025.102918_bib28","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tmaid.2025.102918_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002655","article-title":"PCR-Based techniques for leprosy diagnosis: from the laboratory to the clinic","volume":"8","author":"Martinez","year":"2014","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib30","first-page":"2083","article-title":"Challenges and advances in serological and molecular tests to aid leprosy diagnosis","volume":"248","author":"Lopes-Luz","year":"2023","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.tmaid.2025.102918_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005725","article-title":"Uniform multidrug therapy for leprosy patients in Brazil (U-MDT\/CT-BR): results of an open label, randomized and controlled clinical trial, among multibacillary patients","volume":"11","author":"Penna","year":"2017","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.47276\/lr.90.4.388","article-title":"Levels of disability and relapse in Bangladeshi MB leprosy cases, 10 years after treatment with 6m MB-MDT","volume":"90","author":"Ruth","year":"2019","journal-title":"LEPROSY"},{"key":"10.1016\/j.tmaid.2025.102918_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjid.2024.103745","article-title":"Late relapses in leprosy patients in Brazil: 10-Year post-trial of uniform multidrug therapy (U-MDT\/CT-BR)","volume":"28","author":"Penna","year":"2024","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.47276\/lr.94.4.309","article-title":"A retrospective analysis of leprosy relapse patients after treatment with WHO-MDT at a tertiary institute in South India","volume":"94","author":"Gupta","year":"2023","journal-title":"Lepr Rev"},{"key":"10.1016\/j.tmaid.2025.102918_bib35","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1128\/AAC.45.12.3635-3639.2001","article-title":"Multidrug resistant Mycobacterium leprae from patients with leprosy","volume":"45","author":"Maeda","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tmaid.2025.102918_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/324623","article-title":"Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy","volume":"34","author":"Emmanuelle","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib37","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1016\/j.cmi.2015.08.004","article-title":"Emergence of primary drug resistance to rifampicin in Mycobacterium leprae strains from leprosy patients in India","volume":"21","author":"Lavania","year":"2015","journal-title":"Clin Microbiol Infection"},{"key":"10.1016\/j.tmaid.2025.102918_bib38","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/JCM.06561-11","article-title":"Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients","volume":"50","author":"Rocha","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tmaid.2025.102918_bib39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/ced.12665","article-title":"Drug resistance in Mycobacterium leprae from patients with leprosy in China","volume":"40","author":"Liu","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.tmaid.2025.102918_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.18-0256","article-title":"Kavita. Alternate anti-leprosy regimen for multidrug therapy refractory leprosy: a retrospective study from a tertiary care center in North India","volume":"100","author":"Narang","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2025.102918_bib41","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1056\/NEJMoa2312928","article-title":"Bedaquiline monotherapy for multibacillary leprosy","volume":"391","author":"Barreto","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2025.102918_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12414","article-title":"Leprosy treatment during pregnancy and breastfeeding: a case report and brief review of literature: leprosy during pregnancy and breastfeeding","volume":"30","author":"Ozturk","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.tmaid.2025.102918_bib43","doi-asserted-by":"crossref","first-page":"232","DOI":"10.47276\/lr.91.3.232","article-title":"The adverse drug effects of dapsone therapy in leprosy: a systematic review","volume":"91","author":"Hilder","year":"2020","journal-title":"LEPROSY"},{"key":"10.1016\/j.tmaid.2025.102918_bib44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/tmi.13977","article-title":"Clofazimine\u2010induced cutaneous hyperpigmentation as a source of stigma in the treatment of leprosy: a cross\u2010sectional study","volume":"29","author":"Nogueira","year":"2024","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.tmaid.2025.102918_bib45","article-title":"A review of side-effects experienced by patients taking clofazimine","volume":"54","author":"Moore","year":"1983","journal-title":"Lepr Rev"},{"key":"10.1016\/j.tmaid.2025.102918_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012699","article-title":"A retrospective cohort study of monthly rifampicin, ofloxacin and minocycline in the management of leprosy at the hospital for tropical diseases, London, United Kingdom","volume":"18","author":"Sivakumaran","year":"2024","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib47","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1365-3156.2011.02873.x","article-title":"Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis","volume":"16","author":"Setia","year":"2011","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.tmaid.2025.102918_bib48","doi-asserted-by":"crossref","DOI":"10.1177\/20499361221135885","article-title":"Novel approaches in the treatment of Hansen's disease (leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States","volume":"9","author":"Franco-Paredes","year":"2022","journal-title":"Therapeutic Advances in Infection"},{"key":"10.1016\/j.tmaid.2025.102918_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006011","article-title":"Clinico-pathological features of erythema nodosum leprosum: a case-control study at ALERT hospital, Ethiopia","volume":"11","author":"Negera","year":"2017","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib50","series-title":"Leprosy\/hansen disease: Management of reactions and prevention of disabilities","year":"2017"},{"key":"10.1016\/j.tmaid.2025.102918_bib51","doi-asserted-by":"crossref","first-page":"372","DOI":"10.47276\/lr.79.4.372","article-title":"Leprosy type 1 (reversal) reactions and their management","volume":"79","author":"Walker","year":"2008","journal-title":"Lepr Rev"},{"key":"10.1016\/j.tmaid.2025.102918_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001041","article-title":"A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions And\/Or nerve function impairment","volume":"5","author":"Walker","year":"2011","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.47276\/lr.74.4.311","article-title":"Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3)","volume":"74","author":"Richardus","year":"2003","journal-title":"Lepr Rev"},{"key":"10.1016\/j.tmaid.2025.102918_bib54","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bmj.38107.645926.AE","article-title":"Steroid prophylaxis for prevention of nerve function impairment in leprosy: randomised placebo controlled trial (TRIPOD 1)","volume":"328","author":"Smith","year":"2004","journal-title":"Br Med J"},{"key":"10.1016\/j.tmaid.2025.102918_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.lansea.2025.100555","article-title":"Challenges associated with dapsone for leprosy treatment in Indonesia - urgent need for access to alternative antimicrobial drugs","volume":"34","author":"Krismawati","year":"2025","journal-title":"The Lancet Regional Health - Southeast Asia"},{"key":"10.1016\/j.tmaid.2025.102918_bib56","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s41479-024-00127-x","article-title":"Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?","volume":"16","author":"Ram\u00edrez-Perea","year":"2024","journal-title":"Pneumonia (Nathan Qld)"},{"key":"10.1016\/j.tmaid.2025.102918_bib57","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.trstmh.2003.12.013","article-title":"Clinical outcomes in a randomized controlled study comparing azathioprine and prednisolone versus prednisolone alone in the treatment of severe leprosy type 1 reactions in Nepal","volume":"98","author":"Marlowe","year":"2004","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2025.102918_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.47276\/lr.77.2.121","article-title":"Cyclosporine A treatment of leprosy patients with chronic neuritis is associated with pain control and reduction in antibodies against nerve growth factor","volume":"77","author":"Sena","year":"2006","journal-title":"Lepr Rev"},{"key":"10.1016\/j.tmaid.2025.102918_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004502","article-title":"A randomized controlled double blind trial of ciclosporin versus prednisolone in the management of leprosy patients with new type 1 reaction, in Ethiopia","volume":"10","author":"Lambert","year":"2016","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib60","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/cid\/ciq213","article-title":"Severe refractory erythema nodosum leprosum successfully treated with the tumor necrosis factor inhibitor etanercept","volume":"52","author":"Ramien","year":"2011","journal-title":"Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America"},{"key":"10.1016\/j.tmaid.2025.102918_bib61","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJMc052955","article-title":"Treatment of recurrent erythema nodosum leprosum with infliximab","volume":"355","author":"Faber","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2025.102918_bib62","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1086\/505222","article-title":"Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases","volume":"43","author":"Scollard","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011238","article-title":"Methotrexate as a corticosteroid-sparing agent in leprosy reactions: a French multicenter retrospective study","volume":"17","author":"Jaume","year":"2023","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101670","article-title":"Use of methotrexate for leprosy reactions. Experience of a referral center and systematic review of the literature","volume":"37","author":"Perez-Molina","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib65","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0889-857X(21)00061-2","article-title":"METHOTREXATE: adverse reactions and major toxicities","volume":"20","author":"Goodman","year":"1994","journal-title":"Rheum Dis Clin N Am"},{"key":"10.1016\/j.tmaid.2025.102918_bib66","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/jdds.jdds_45_23","article-title":"Apremilast in erythema nodosum leprosum: a case series","volume":"28","author":"Mandloi","year":"2024","journal-title":"Journal of Dermatology and Dermatologic Surgery"},{"key":"10.1016\/j.tmaid.2025.102918_bib67","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjd.18233","article-title":"Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases","volume":"182","author":"Narang","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tmaid.2025.102918_bib68","doi-asserted-by":"crossref","first-page":"e917","DOI":"10.1111\/jdv.17585","article-title":"Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single\u2010centre pilot study","volume":"35","author":"Narang","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.tmaid.2025.102918_bib69","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/ijd.15205","article-title":"Erythema nodosum leprosum successfully treated with apremilast: more effective and safer than classic treatments?","volume":"60","author":"S\u00e1nchez-Mart\u00ednez","year":"2021","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.tmaid.2025.102918_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dth.15258","article-title":"Successful treatment of erythema nodosum leprosum with apremilast","volume":"35","author":"Abril-P\u00e9rez","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.tmaid.2025.102918_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19552","article-title":"Effective management of severe chronic erythema nodosum leprosum in adolescent patient using ustekinumab and apremilast: a case report","volume":"38","author":"Mengeot","year":"2024","journal-title":"Acad Dermatol Venereol"},{"key":"10.1016\/j.tmaid.2025.102918_bib72","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/bcp.12448","article-title":"The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers","volume":"78","author":"Liu","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.tmaid.2025.102918_bib73","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1111\/ajd.14364","article-title":"Tuberculosis reactivation following apremilast therapy for psoriasis: time to consider routine TB screening?","volume":"65","author":"Adams","year":"2024","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.tmaid.2025.102918_bib74","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X20930116","article-title":"Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors","volume":"12","author":"Evangelatos","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib75","series-title":"The selection and use of essential medicines 2023: executive summary of the report of the 24th WHO expert committee on the selection and use of essential medicines","first-page":"24","article-title":"Web annex A. World health organization model list of essential medicines \u2013 23Rd list, 2023","year":"2023"},{"key":"10.1016\/j.tmaid.2025.102918_bib76","article-title":"Challenges of the public health response to a rare case of non-autochthonous Mycobacterium leprae, Ireland","volume":"30","author":"Marshall","year":"2024","journal-title":"Euro Surveill"},{"key":"10.1016\/j.tmaid.2025.102918_bib77","series-title":"Leprosy\/hansen disease: contact tracing and post-exposure prophylaxis","year":"2020"},{"key":"10.1016\/j.tmaid.2025.102918_bib78","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","article-title":"Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial","volume":"336","author":"Moet","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.tmaid.2025.102918_bib79","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s12879-018-3402-4","article-title":"An enhanced regimen as post-exposure chemoprophylaxis for leprosy: pep++","volume":"18","author":"Mieras","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib80","first-page":"73","article-title":"BCG vaccines: WHO position paper \u2013 february 2018","volume":"93","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.tmaid.2025.102918_bib81","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1699-0463.1991.tb05127.x","article-title":"Improving on BCG","volume":"99","author":"Stanford","year":"1991","journal-title":"APMIS"},{"key":"10.1016\/j.tmaid.2025.102918_bib82","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1586\/erv.09.161","article-title":"BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control","volume":"9","author":"Merle","year":"2010","journal-title":"Expet Rev Vaccine"},{"key":"10.1016\/j.tmaid.2025.102918_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004507","article-title":"Leprosy new case detection trends and the future effect of preventive interventions in Par\u00e1 state, Brazil: a modelling study","volume":"10","author":"De Matos","year":"2016","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2025.102918_bib84","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.trstmh.2008.04.015","article-title":"Effectiveness of BCG vaccination among leprosy contacts: a cohort study","volume":"102","author":"D\u00fcppre","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2025.102918_bib85","doi-asserted-by":"crossref","first-page":"606","DOI":"10.25259\/IJDVL_1172_2023","article-title":"MIP vaccine in leprosy: a scoping review and future horizons","volume":"90","author":"Narang","year":"2024","journal-title":"IJDVL"},{"key":"10.1016\/j.tmaid.2025.102918_bib86","doi-asserted-by":"crossref","first-page":"119","DOI":"10.47276\/lr.76.2.119","article-title":"Curing the stigma of leprosy","volume":"76","author":"Rafferty","year":"2005","journal-title":"LEPROSY"},{"key":"10.1016\/j.tmaid.2025.102918_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003440","article-title":"Interventions to reduce leprosy related stigma: a systematic review","volume":"4","author":"Willis","year":"2024","journal-title":"PLOS Glob Public Health"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893925001243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893925001243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:29:37Z","timestamp":1773296977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893925001243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":87,"alternative-id":["S1477893925001243"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2025.102918","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, therapeutic, and stigma-related challenges in leprosy and the emerging role of apremilast in managing leprosy reactions","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2025.102918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102918"}}